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Summary
The paramyxovirus hemagglutinin-neuraminidase (HN)
functions in virus attachment to cells, cleavage of sia-
lic acid from oligosaccharides, and stimulating mem-
brane fusion during virus entry into cells. The struc-
tural basis for these diverse functions remains to be
fully understood. We report the crystal structures of
the parainfluenza virus 5 (SV5) HN and its complexes
with sialic acid, the inhibitor DANA, and the receptor
sialyllactose. SV5 HN shares common structural fea-
tures with HN of Newcastle disease virus (NDV) and
human parainfluenza 3 (HPIV3), but unlike the pre-
viously determined HN structures, the SV5 HN forms
a tetramer in solution, which is thought to be the
physiological oligomer. The sialyllactose complex re-
veals intact receptor within the active site, but no ma-
jor conformational changes in the protein. The SV5
HN structures do not support previously proposed
models for HN action in membrane fusion and sug-
gest alternative mechanisms by which HN may pro-
mote virus entry into cells.
Introduction
The paramyxovirus family of enveloped, negative-
stranded RNA viruses has many members and includes
parainfluenza viruses 1–5, mumps virus, measles virus,
Newcastle disease virus (NDV), Sendai virus, Nipah
virus, Hendra virus, and respiratory syncytial virus. The
viruses possess two major spike glycoproteins, one in-
volved in cell attachment (HN, H, or G), and the other
glycoprotein (F) involved in mediating pH-independent
fusion of the viral envelope with the plasma membrane
of the host cell.
For many of the paramyxoviruses (e.g., parainfluenza
virus 5 [SV5], human parainfluenza viruses 1–4, NDV,
Sendai virus, mumps virus), the attachment protein
(HN) has hemagglutinating and neuraminidase (NA)
activities. HN binds to sialic acid-containing cell sur-
face molecules; furthermore, HN mediates enzymatic
cleavage of sialic acid from the surface of virions and
the surface of infected cells (reviewed in Lamb and Ko-
lakofsky, 2001). It is thought that NA activity is required
to remove sialic acid from the viral and cellular conju-
gates during viral assembly, to allow release of newly*Correspondence: tedj@northwestern.edubudded virus from the virus-infected cell (reviewed in
Choppin and Scheid, 1980).
In addition to receptor binding and NA activity, HN
has a fusion-promoting activity that plays an important
role in virus-cell fusion. The coexpression of HN and F
derived from the same paramyxovirus lowers the acti-
vation energy barrier for triggering F protein-mediated
fusion (Russell et al., 2001). Coimmunoprecipitation as-
says suggest that F and HN exist in a complex, and a
great deal of effort has been spent to map the regions
of F and HN that interact. Mutations have been iden-
tified in several domains of HN that decrease or abolish
fusogenic activity with no effect on receptor recognition
(reviewed in Colman and Lawrence, 2003). However, a
consensus view of the domains of interaction between
HN and F has not been obtained to date.
HN is a type II integral membrane protein that spans
the membrane once and contains an N-terminal cyto-
plasmic tail, a single N-terminal transmembrane (TM)
domain, a membrane-proximal stalk domain, and a
large C-terminal globular head domain (Hiebert et al.,
1985). The globular head domain contains the receptor
binding and enzymatic activity (Parks and Lamb, 1990;
Scheid et al., 1972; Thompson and Portner, 1987). HN
is glycosylated and noncovalently associated to form a
tetramer, based on biochemical, crosslinking, and
electron microscopy studies, which, depending on the
virus, can be composed of two disulfide-linked dimers
(McGinnes et al., 1993; Ng et al., 1989, 1990; Thompson
et al., 1988). The covalent linkage occurs through a cys-
teine residue in the stalk domain. The specific residues
involved in tetramer association have not been iden-
tified but have been suggested to reside in the TM do-
main, the cytoplasmic domain, the extracellular do-
main, or in all three domains (Parks and Lamb, 1990;
Takimoto et al., 1992; Thompson et al., 1988).
The structure of the enzymatically active head do-
main of HN had been predicted to be similar to other
neuraminidases or sialidases, such as influenza NA
(Epa, 1997), with the globular head composed of iden-
tical subunits arranged with 4-fold symmetry. Each NA
domain was expected to exhibit the six-blade-propeller
fold typical of other neuraminidase/sialidase structures
from viral, protozoan, or bacterial origin (Buschiazzo et
al., 2000, 2002; Langedijk et al., 1997; Taylor, 1996). The
predicted structure of the HN NA domain was con-
firmed in the X-ray structures of soluble NDV and HPIV3
HN globular NA regions (Crennell et al., 2000; Lawrence
et al., 2004). While the NDV and HPIV3 HN-soluble NA
domains are monomeric in solution, both form similar
dimer interactions in their respective crystals. A poten-
tial tetrameric arrangement for the NDV HN NA domains
was recently proposed, and a second sialic acid bind-
ing site at the previously observed dimer interface was
identified (Zaitsev et al., 2004).
Here, we report the structure of the tetrameric ecto-
domains of SV5 HN and crystallographic studies with
sialic acid, the inhibitor DANA (2,3-dehydro-2-deoxy-N-
acetylneuraminic acid), and the substrate/receptor tri-
saccharide sialyllactose. Sialyllactose is observed as
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athentic receptor complex. Crystals soaked with sialic
sacid reveal electron density consistent with the inhibitor
pDANA, suggesting that SV5 HN can catalyze this reac-
ation, as observed for other neuraminidases. SV5 HN
Cforms dimers that are very similar to the previously de-
tscribed NDV and HPIV3 dimers, suggesting that this
Coligomeric arrangement is well conserved. SV5 HN also
nforms a potential tetramer in the crystals, through the
iassociation of two dimers. The observed tetramer ar-
irangement is analogous to that described for NDV HN,
but with significant shifts in dimer packing angles and
iresidue positions. Implications from these structures
dfor understanding the coupling of receptor binding and
pmembrane fusion are discussed.
s
aResults and Discussion
8
fStructure Determination
lBoth the SV5 HN globular NA domain (HNNA), residues
t115–565, and the entire HN ectodomain (HNecto), resi-
Sdues 37–565, were expressed in insect cells by using
bthe baculovirus system (Figure 1). Secreted HN protein
Iwas purified to homogeneity by using metal chelate
fand gel filtration chromatography. Purified HNNA mi-
(grates as a monomer, as analyzed by both gel filtration
Hchromatography and SDS-PAGE. In contrast, purified
SHNecto elutes from a gel filtration column with an appar- pent molecular weight of approximately 265 kDa, close
Nto the predicted tetramer molecular weight (250–260
ikDa). In reducing SDS-PAGE gels, HNecto migrates with athe expected monomer molecular weight of 58 kDa,
while, on nonreducing SDS-PAGE, HNecto migrates squantitatively at the predicted dimer molecular weight
d(Figure 1B). These observations indicate that HNecto s
forms disulfide-linked dimers through C111 and that
c
the dimers associate into tetramers in solution, consis-
o
tent with previous studies of the HN oligomeric ar- c
rangement (Ng et al., 1990). The formation of a stable
HN tetramer in solution requires the N-terminal stalk re- C
gion of the protein. Gel filtration analysis of HNecto at M
concentrations from 30 nM to 2 M show no changes S
in the elution peak of the protein, suggesting that the a
tetrameric arrangement is stable over this concentra- C
tion range. Both HNecto and HNNA exhibit NA activity. o
SV5 HNecto (henceforth referred to as SV5 HN) was b
crystallized (Table 1), and the structure was solved by (
molecular replacement (Figure 2). SDS-PAGE analysis t
of dissolved crystals (Figure 1B) shows that the intact (
HNecto protein is present in the crystals. Complexes a
with sialic acid (at pH 7 and 8), with the inhibitor DANA c
(at pH 7 and 8), and with sialyllactose (at pH 8) have t
also been determined. The resolution of the crystal a
structures ranges from 2.3 to 2.8 Å; final refinement sta-
tistics were collected and are shown in Table 1. N
The globular NA domain of SV5 HN (residues 118– N
565) exhibits the typical sialidase/neuraminidase fold a
consisting of six antiparallel β strands organized as a N
superbarrel, with a centrally located active site (Figure l
2A). In all of the structures, the stalk region (residues b
37–117) is not visible in electron density maps, although o
some additional electron density is observed extending v
tfrom residue 118 that could not be modeled. These ob-ervations suggest that the HN stalk is unstructured or
dopts multiple conformations in the crystal. The HN
tructure contains seven disulfide linkages. In a com-
arison of 16 HN sequences, 4 of these are between
bsolutely conserved cysteines (C161–C185, C227–
240, C448–C458, and C528–C539). The remaining
hree are less well conserved. C175–C236 and C333–
454 are conserved in 10 of 16 sequences, but they are
ot observed in HPIV3 HN. C365–C375 is not observed
n either HPIV3 or NDV sequences, but it is still found
n 10 of 16 HN sequences.
The electron density for residues 186–190 (Figure 2)
s variable in the data sets collected. Good electron
ensity for these amino acids is observed in the com-
lexes with sialyllactose soaked at pH 8.0, sialic acid
oaked at both pH 7.0 and pH 8.0, and DANA soaked
t pH 8.0. However, for the unliganded crystals at pH
.0 and for DANA soaked at pH 7.0, the electron density
or this region is poor. Residues 186–190 form a loop
ocated on the top of the active site (Figure 2) and con-
ain a highly conserved aspartic acid (D187, Table 2). In
V5 HN, this loop appears to be flexible, but this flexi-
ility is not simply correlated with ligand binding or pH.
t is not clear whether loop flexibility is important for HN
unction, but its conformation differs in the SV5, NDV
Crennell et al., 2000), and HPIV3 (Lawrence et al., 2004)
N structures. In NDV HN, mutation of D198 (D187 in
V5) affects receptor binding, NA activity, and fusion
romotion (Deng et al., 1999). D198 is ordered in the
DV unliganded and sialic acid bound structures, but
t is disordered in the inhibitor complex (Crennell et
l., 2000).
In the SV5 HN structures, electron density is ob-
erved at predicted N-linked glycosylation sites (resi-
ues 139, 267, and 504) and for a calcium ion at a con-
erved binding site. The Ca2+ is coordinated by the
arbonyl oxygen of D250, the hydroxyl and carbonyl
xygens of S253, the carbonyl oxygen of A285, and the
arbonyl oxygen of A255.
omparison of the SV5, NDV, and HPIV3 HN
onomer Structures
uperposition of the SV5 HN monomer onto NDV HN
nd HPIV3 HN monomers over 447 and 431 equivalent
α positions (Figure 2C) yields rmsds in Cα positions
f 1.2 Å2 for NDV and 1.9 Å2 for HPIV3. A structure-
ased sequence alignment of SV5, NDV, and HPIV3
Figure 1C) indicates that SV5 HN has higher similarity
o NDV HN (30%) and lower similarity to HPIV3 HN
21%). Overall, there are 79 conserved residues across
ll 3 sequences, corresponding to w15% of the extra-
ellular region. The major structural differences appear
o be near insertion and deletion sites (Figure 1C) that
re located at surface regions in the NA domain.
Many of the largest structural differences in the SV5,
DV, and HPIV3 HN proteins cluster to one side of the
A domain, forming a highly variable face (Figures 2C
nd 2D). In particular, differences in residues in the
-terminal 133 region, the α3-α4 helical region, the 424
oop, and the 476 loop define a markedly different
road surface in each of the HN proteins, with a number
f potential N-linked glycosylation sites. Both the high
ariability and location of potential N-linked glycosyla-
ion sites suggest that this surface is not critical for
SV5 HN Structure
805Figure 1. HN Expression Constructs and Sequence Comparison
(A) Constructs for expression of HNecto and HNNA in insect cells. Downward arrowheads correspond to protease cleavage sites in the
pBACgus-3 vector.
(B) SDS-PAGE analysis of HNecto, HNNA, and dissolved HNecto crystals under reducing and nonreducing conditions. Standards in lanes 1 and
6 correspond to molecular weights of 224, 122, 96, 52, 35, and 29 kDa, respectively.
(C) Structure-based sequence alignment of SV5, HPIV3, and NDV HN. The numbers above the alignment are from SV5 HN. Conserved residues
are outlined with red background, and semiconserved residues are outlined with blue boxes. The blue pentagons indicate glycosylation sites
at residues 139, 267, and 504. The residues buried in the dimer interface are marked by purple lines. The magenta line shows the missing
loop positions at residues 186–190 in the ligand-free and DANA bound structures. Yellow squares indicate the conserved residues at the
active site. Secondary structure elements are indicated with α helices outlined green boxes with helix signs and β strands shown as plain
green, solid boxes. The nomenclature βiSj corresponds to the jth strand in the ith β sheet. Helices are named according to NDV HN counter-
parts, with α2 missing and the additional helices given as α0 and α5.conserved functions of HN, such as interactions with F,
and may instead represent adaptive changes associ-
ated with evasion of the immune response. However, it
is possible that changes in this highly variable face or
some of the other surface regions could influence the
specificity of HN/F interactions.Complexes of HN with Ligands
Ligand complexes were obtained by soaking crystals
with sialic acid, DANA, and sialyllactose at the different
pH values and time points listed in Table 1. Good
electron density for ligands within the active sites was
observed for all soaks (Figure 3). Comparison of the
Structure
806Table 1. Data Collection and Refinement Statistics
Complexes
Unliganded Sialic Acid- Sialic Acid- Sialyllactose
(pH 7.0) Soaked (pH 7.0) Soaked (pH 8.0) DANA (pH 7.0) DANA (pH 8.0) (pH 8.0)
Data Collection Statistics
Resolution range (Å) 2.6 2.5 2.8 2.3 2.7 2.5
Cell Dimensions
a = b (Å) 137.6 137.9 137.7 137.8 138.0 137.1
c (Å) 184.9 184.8 184.9 184.9 185.0 184.4
Unique reflections/total 31,340/151,542 35,941/213,995 26,160/188,850 46,072/247,809 27,908/197,963 35,595/244,365
Completeness/last shell 96.5/96.6 92.0/98.3 100.0/100.0 98.1/98.7 83.4/95.4 98.3/98.6
(%)
Redundancy 4.8 6.0 7.2 5.4 7.1 6.9
I/σ(I) (last shell) 14.6 (3.2) 17.7 (3.4) 17.6 (5.5) 19.5 (3.8) 19.4 (4.1) 23.7 (6.5)
Rmerge (last shell) % 9.8 (42.7) 7.8 (41.1) 11.9 (39.4) 7.9 (43.3) 8.3 (34.6) 7.8 (28.9)
Refinement
Number of reflections 30,405/926 34,874/1,013 25,368/725 44,732/1,308 27,105/792 34,550/1,017
work/test
Number of protein atoms 3,449 3,491 3,491 3,461 3,491 3,491
Number of ligand atoms 0 20 20 20 20 43
Number of water 192 203 192 217 163 241
molecules
Average B factor 30.4 34.9 27.6 33.6 36.4 29.2
Protein 29.0 34.0 26.4 32.6 35.7 27.8
Water 34.3 35.5 31.4 36.1 35.3 31.5
Rmsd bonds (Å) 0.007 0.006 0.007 0.008 0.007 0.007
Rmsd angles (o) 1.47 1.43 1.45 1.46 1.42 1.44
Rwork /Rfree, (%) 21.6/23.6 20.3/22.6 19.9/22.4 20.6/22.6 19.8/22.2 19.9/22.1
Ramachandran Statistics
Favorable (%) 85.9 85.7 84.9 85.7 84.6 84.9
Additional (%) 13.5 13.8 14.6 13.8 14.6 14.6
Generous (%) 0.5 0.3 0.5 0.5 0.8 0.5
Disallowed (%) 0.0 0.3 0.0 0.0 0.0 0.0active sites of the ligand bound and free SV5 HN struc- s
rtures reveals no major changes of the residue positions
upon ligand binding (Figure 4), in contrast to observa- t
ttions made for both the NDV and HPIV3 HN structures.
In this way, the SV5 site appears to be more similar to H
athe rigid active sites observed for influenza A and B
neuraminidases.
C
EThe Unbound Active Site
Seven highly conserved active site residues in neur- d
uaminidases and sialidases (R163, D187, E390, R405,
R495, Y523, and E544) are shown in Table 2; the num- p
dbers corresponding to the SV5, NDV, and HPIV3 HN se-
quences are also shown. The three conserved argi- b
onines, R163, R405, and R495, are positioned to interact
with the sialic acid carboxylate, even in the absence of R
cligand. Two water molecules are observed at positions
corresponding to the substrate carboxylate oxygens, s
aand these water molecules form a hydrogen bonding
network with the conserved arginine triad (Figures 4A E
sand 4B). Residues Y523 and E390 are positioned at the
base of the active site. In complexes with ligand, these
rtwo residues are positioned underneath the glycosidic
bond to be cleaved and participate directly in catalysis. R
dE544 is located behind R163, forming a bidentate salt
bridge interaction between the carboxylate oxygens o
aand two of the guanidinium group nitrogens. There is
no evidence for a bridging water molecule between r
bR163 and E544, as observed in the HPIV3 and NDV HNtructures. Instead, the tight R163:E544 interaction cor-
esponds more closely to influenza A and B NA struc-
ures and may partially explain the apparent rigidity of
he SV5 HN active site as compared to NDV and HPIV3
N. Residues 186–190, including the conserved D187,
re disordered.
omplex Soaked with DANA
lectron density maps from DANA-soaked crystals un-
er both pH conditions show the bound inhibitor (Fig-
re 3A). The active site is open to solvent with DANA
ositioned at the bottom of a large cavity. Twelve resi-
ues, comprising a total surface area of 232 Å2, are
uried by DANA binding. The buried residues include 5
f the 7 conserved active site residues, R163, E390,
405, R495, and Y523 (Figures 4C and 4D). E544, lo-
ated behind R163, is already substantially buried from
olvent, while D187 is disordered in this complex. In
ddition to the conserved residues, I164, S226, F241,
247, Y306, F353, and N407 are also buried from
olvent by DANA.
The carboxylate oxygens of DANA interact asymmet-
ically with the conserved arginine triad, R163, R405,
495, while the carbon atoms of the sugar make van
er Waals contacts with HN residues. One carboxylate
xygen (O1A) of DANA interacts with R163 Nη1, Nη2,
nd R495 Nη1 with distances of 3.0 Å, 3.1 Å, and 2.7 Å,
espectively (Figures 4C and 4D), while the second car-
oxylate oxygen (O1B) interacts with R495 Nη2 and
SV5 HN Structure
807Figure 2. SV5 HN Monomer Structure and
Comparison with NDV HN and HPIV3 HN
(A and B) Schematic cartoon diagrams
showing top and side views of SV5 HN. Heli-
ces are shown in cylinders, and β strands are
shown in arrowed belts. The N terminus is
shown in blue, and the C terminus is shown
in red. The missing loop from residues 186–
190 is indicated as a dashed blue line.
(C and D) Cα ribbon diagram of the superpo-
sition of SV5 HN with NDV and HPIV3 HN,
shown in top and side views. Major differ-
ences in the SV5, NDV, and HPIV HN struc-
tures are colored red, blue, and green,
respectively. Areas of major structural differ-
ences are labeled, and the highly variable
face of the HN monomer is highlighted.R405 Nη2 at distances of 2.6 Å and 3.1 Å, respectively.
Beneath the ligand, Y523 and E390 hydrogen bond to
each other, with Y523 making additional potential hy-
drogen bonds to the ligand ring oxygen (O6) and R405.
At the other end of the ligand, N5 forms hydrogen
bonds to a water molecule located underneath DANA
that is in a tight network with S226, Y306, and E390.
This water molecule is also observed in the free HN
structure. The glycerol moiety of DANA fits into a side
pocket of the active site formed by E247, Y251, Y306,
F353, E390, and R405. E247 makes two hydrogen
bonds to O7 and O9 of DANA. O8 of the glycerol moiety
points down into the active site, forming a hydrogen
bond with a buried water molecule involved in a net-
work of interactions that includes the E390 main chain
nitrogen, another buried water, the carbonyl of G388,
and the side chain of N407. The E544 carboxylate main-
tains a bidentate interaction with the R163 guanidi-
nium group.
Complex Soaked with Sialic Acid
While the reaction mechanism of viral NAs is not com-
pletely understood, hydrolysis is thought to involve the
induction and stabilization of an oxocarbonium ion in-Table 2. Conserved Active Site Residues
HPIV3 NDV SV5
R1 192 174 163
R4 424 416 405
R5 503 498 495
Y6 530 526 523
E4 409 401 390
E6 549 547 544
D1 216 198 187termediate (Janakiraman et al., 1994) and involve pro-
ton donors, which may be either protein residues
(Ghate and Air, 1998) or water molecules (Taylor and
von Itzstein, 1994). For the sialic acid complexes, we
observed electron density consistent with the inhibitor
DANA at both pH 7 and pH 8 (Figure 3B). Electron den-
sity for the O2 atom is not evident, and the sialic acid
moiety appears to adopt a planar conformation, consis-
tent with either the direct synthesis of DANA from sialic
acid (Burmeister et al., 1993) or the formation of an oxo-
carbonium intermediate in the active site (Janakiraman
et al., 1994). The analysis of the substrate density sug-
gests that SV5 HN, like NDV HN and influenza B virus
NA (Burmeister et al., 1993; Crennell et al., 2000), can
synthesize DANA from sialic acid. For influenza B virus
NA, the conversion of sialic acid to DANA has been
shown to be a slow process, resulting from the high
concentrations of both NA and sialic acid present in the
crystallographic experiments, and it is not likely to af-
fect NA activity in vivo. Overall, the structures of sialic
acid-soaked HN crystals do not reveal any major differ-
ences compared to the DANA-soaked complexes.
Complex Soaked with Sialyllactose
Crystals were soaked with either a mixture of α(2,3#)-
and α(2,6#)-sialyllactose, or only α(2,3#)-sialyllactose
(Neu5Acα2 / 3#Galβ1 / 4Glc). The intact sialyllac-
tose ligand, representing a model receptor:HN com-
plex, is observed. HNecto enzymatic activity is optimal
at low pH (4.0–6.0), but it drops off at pH 6.5–7.0 and is
down by over 5-fold at pH 8 in solution, the pH of these
soaking experiments (Scheid and Choppin, 1974).
HNecto NA activity is also further inhibited (w2×) by 250
mM NaCl present in the crystallization buffer. Under all
soaking conditions, we observed electron density con-
Structure
808Figure 3. Electron Density Observed for Li-
gand-Soaked Crystals
(A) DANA electron density at 2.3 Å reso-
lution.
(B) Sialic acid-soaked crystal (modeled as
DANA) at 2.5 Å resolution.
(C) α2,3-sialyllactose at 2.5 Å resolution. Ste-
reo views of the electron density for the li-
gands from composite omit 2Fo − Fc maps
contoured at 0.9 σ are shown. The figures
were generated with Pymol (DeLano, 2002).sistent only with α(2,3#)-sialyllactose (Figure 3C), sug-
cgesting either that SV5 HN has a binding preference for
α(2,3#)- over α(2,6#)-sialyllactose or, alternatively, that p
sSV5 HN can more effectively hydrolyze α(2,6#)-sialyllac-
tose in the crystal. We have tested whether α(2,6#)-sial- t
tyllactose is a substrate for HNecto, and we observe
reduced activity (data not shown), suggesting a prefer- s
eence for α(2,3#)-sialyllactose. The relatively high pH of
the crystals likely limits substrate protonation at the o
glycosidic oxygen, reducing catalytic turnover. In other
NAs, the conserved residue D187 is thought to play a t
(role in glycosidic bond cleavage, potentially through a
water molecule; however, in the sialyllactose complex, p
athis residue is pointed away from the active site. The
observed conformational flexibility of the 186 loop and f
oits positioning away from the active site may also con-
tribute to the slowed catalysis of the ligand. The HNecto a
apH profile is consistent with either a role of solvent pro-
tons in the catalytic mechanism or, alternatively, with l
tthe involvement of an enzyme residue with a nearly
neutral pK . iaTo test whether residual NA activity in the crystal
ould convert the α(2,3#)-sialyllactose to a mixture of
roduct and substrate during the time course of the
oaking experiments, we collected data sets for crys-
als soaked from 2 hr up to 3 days (Table 3). For all of
he crystals, the observed electron density was similar,
uggesting that the enzymatic turnover rate was slow
nough to prevent conversion of the substrate pool
ver this time.
The observed sialyllactose electron density is consis-
ent with a deformed conformation for the saccharide
Figure 3C), similar to the structure of a Michaelis com-
lex observed for a Trypanosoma cruzi trans-sialidase
nd other glycosidases (Amaya et al., 2004). In this con-
ormation, the α(2,3#) glycosidic bond to be cleaved is
riented in a pseudo-axial position, while the carboxyl-
te moiety projects equatorially toward the conserved
rginine triad (Figures 4E and 4F). The HN complex
ikely represents a distorted state prior to the authentic
ransition state (Ghate and Air, 1998) or oxocarbonium
on intermediate (Janakiraman et al., 1994).
SV5 HN Structure
809Figure 4. Comparison of Active Sites in the Absence and Presence of Ligands
(A–F) Active sites are shown in two views, rotated 90° from each other. Surrounding protein side chains and water molecules are shown,
with waters as spheres and hydrogen bonds as blue dotted lines. (A and B) Unliganded active site. (C and D) DANA complex. (E and F)
Sialyllactose complex.The lactose moiety is positioned around the α(2,3#)
linkage to one side of the large active site cavity close
to W352. Fifteen HN residues, with a total buried sur-
face of 329 Å2, are buried by the receptor. Only 107 Å2
of the active site are buried by the larger lactose moiety,
consistent with its limited interactions in the cavity.
Compared to the complex with DANA, only 3 additional
residues—Q186, W352, and L459—are buried by sialyl-
lactose, although the lactose does bury additional sur-
face area of a subset of the other 12 residues. For ex-ample, while DANA buries 15 Å2 of R495, in the
sialyllactose complex, 32 Å2 of this residue is buried.
The lactose moiety is positioned above the end of the
side chain of R495. The electron density in composite
omit maps is best for the sialic acid region and is pro-
gressively weaker for the galactose and glucose moie-
ties, consistent with the fewer contacts made by the
sugar as it extends out of the active site (Figure 3C).
This difference is also observable as a gradient of
increasing temperature factors along the polysaccha-
Structure
810ride chain, with values near 30 Å2 for sialic acid and o
fnear 75 Å2 for the terminal glucose moiety.
Overall, the sialic acid moiety interacts with residues
lof the active site similarly to the DANA complex, and
only minor adjustments of active site residues are ob- (
aserved. The conserved arginine triad interacts with the
sialic acid carboxylate. In sialyllactose, the C2 carbon t
mof sialic acid adopts a tetrahedral geometry and there-
fore projects slightly higher from the base of the active c
fsite above Y523 and E390. Y523 lies underneath the
sialic acid and is stabilized by hydrogen bonds with
tE390 and R405, in addition to a potential hydrogen
bond with the sialic acid ring oxygen (O6). The hy- b
Hdrogen bond networks around the glycerol moiety and
N5 of the N-acetyl group are also observed in this com- c
gplex. E544 and R163 retain their bidentate interaction,
as observed in all of the HN structures. m
SComparison of HN Dimers
SV5 HN forms a disulfide bonded dimer based on non- R
ireducing SDS-PAGE. Although the crystals contain a
monomer in the asymmetric unit, crystallographic sym- s
mmetry generates HN dimers that are similar to those
previously described for NDV and HPIV3 HN proteins. u
sIn the electron density maps, the N-terminal residues
of the SV5 HN monomers extend toward the dimer e
sinterface, potentially meeting at A116. C111 (Figure 1)
in each monomer could then form an interchain disul- s
pfide bond between these monomers, consistent with
the observed oligomeric state in solution. The calcu- c
clated buried surface area for each monomer in the SV5
HN dimer is 1810 Å2. Superposition of SV5 HN with NDV
bHN and HPIV3HN (Figure 5) shows that these proteins
all form similar dimers with rmsds in Cα positions of f
11.4 Å2 and 1.9 Å2, respectively. The dimer places the
two HN active sites at nearly 90° angles relative to each sTable 3. Sialyllactose Soaks
2,3#-SL or 2,3#-SL/2,6#-SL
Mixture (Concentration, mM) Time (hr) Resolution (Å) Rmerge (%) Density for 2,3#-SL
Mixture (10) 16 2.5 7.8 +
2,3#-siallylactose (15) 2 3.0 13.5 +
2,3#-siallylactose (15) 16 3.0 10.2 +
2,3#-siallylactose (15) 72 2.95 11.0 +egments, and, in monomer 2, residues 553 and 168–
Figure 5. Comparison of SV5, NDV, and
HPIV3 HN Dimers
Cα traces of the superposition of the three
HN dimers. SV5 HN, NDV HN, and HPIV3 HN
dimers are shown in red, blue, and green,
respectively. The HN variable faces are indi-
cated.ther, with a 2-fold axis oriented approximately 45°
rom the top of the NA domain.
The highly variable surface of the HN monomers is
ocated on the outer edges of the long axis of the dimer
Figure 5), while 47 residues (Figure 1) of more structur-
lly conserved regions are involved in the dimer in-
eraction. Four prolines interact at the center of the di-
er interface; of these, P149 and P153 from both
hains and aromatic residues (F194, F209, and Y217)
orm a hydrophobic cluster on one side of the prolines.
There is no evidence from the SV5 HN complex struc-
ures that the dimer interface changes upon ligand
inding, as suggested by structural studies of the NDV
N (Crennell et al., 2000). The SV5 HN crystals do not
rack upon ligand soaking, at either pH studied, sug-
esting that binding does not significantly alter HN di-
erization and packing interactions.
V5 Lacks a Second Binding Site for Sialyllactose
ecently, a potential second binding site for sialic acid
n NDV HN, located at the dimer interface, was de-
cribed (Zaitsev et al., 2004). In our experiments, 15
M sialyllactose (Table 3), similar to the concentrations
sed to identify the NDV second binding site with a
ialyllactose analog, was soaked into crystals. How-
ver, no electron density for this second site is ob-
erved in the SV5 HN complexes, suggesting that the
econd binding site is nonfunctional in SV5. The pro-
osed second binding site is located near a solvent
hannel in the SV5 HN crystals and is not blocked by
rystal packing.
In the NDV HN structures, the second sialic acid
inding site is formed by four polypeptide segments
rom the two HN monomers (Figure 6A). In monomer
, residues 514–519 and 155–156 make up two of the
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(A) Location of the second site in NDV HN. NDV HN residue num-
bers are shown.
(B) Superposition of SV5 and NDV HN at the second site. The NDV
HN is shown as green, and SV5 HN is shown as blue. SV5 residue
numbers are shown. The hydrogen bonds are indicated as dashed
blue lines. P158 in SV5 HN replaces G169 in NDV HN, which forms
a potential hydrogen bond with sialic acid.169 make up the final two segments. The majority of
hydrogen bonds between sialic acid and HN are formed
with monomer 1, with only a single hydrogen bond
formed by G169 in monomer 2 (Zaitsev et al., 2004).
Superposition of the SV5 dimer onto the NDV dimer
reveals a number of structural changes that would sig-
nificantly disrupt the second sialic acid binding site.
The sialic acid moiety at the NDV HN second site in-
teracts with nonconserved residues (Figure 6B). In SV5
HN, the NDV G169 residue in monomer 2 is replaced by
P158, which cannot hydrogen bond to the ligand. In
monomer 1, SV5 residues 510–515 and 144–145, corre-
sponding to the two interacting segments in NDV HN,
are displaced such that additional hydrogen bond in-
teractions with the sialic acid would be disrupted. The
observed structural differences are consistent with a
lack of electron density in the sialyllactose-soaked SV5
HN complexes and suggest that this second site is not
functional in SV5.
SV5 HN Tetramers
Based on gel filtration chromatography, SV5 HN likely
forms a tetramer in solution. In the HN crystal lattice,
the SV5 HN NA domain forms a continuous ribbon of
dimers and tetramers aligned along the crystallo-graphic 6-fold axis. The potential tetramer is the only
crystallographic arrangement for a tetramer consistent
with the HN dimer (Figures 7A and 7B), and it places
the N termini of the four monomers on one face, consis-
tent with anchoring to a membrane surface. In addition,
the variable face of the HN NA domain is positioned to
the outside of the tetramer, consistent with a common
oligomer arrangement for diverse paramyxovirus HN
proteins. However, unlike typical protein tetramers, the
SV5 HN tetramer is arranged with two 2-fold symmetry
axes (Figures 7A–7C) that are not oriented at 90° to
each other, allowing neighboring dimers and tetramers
to associate into infinitely long oligomers. Because of
this, we describe the HN tetramer as a dimer-of-dimers
lacking closed symmetry.
While the observed SV5 HN tetramer can in principle
form infinite helical ribbons because of its open sym-
metry, the interaction between NA domain dimers is
weak. HNecto migration on gel filtration columns does
not change at concentrations of up to w2 M, indicat-
ing that any interactions between tetramers are sub-
stantially weaker than this. In a lipid membrane, the as-
sembly of multiple neighboring tetramers into a longer
oligomer, as observed in the crystal, is not compatible
with the anchoring of HN to the cell membrane, and
this also likely contributes to limiting the physiological
oligomerization of the protein. Based on EM images,
Sendai virus HN, like influenza virus NA, exhibits a box-
shaped arrangement consistent with four discrete sub-
units (Thompson et al., 1988; Varghese et al., 1983).
In contrast to the HN dimer interaction, the dimer-
of-dimers interface is much smaller, involving only ten
residues and burying only 657 Å2. The buried residues
are primarily located on loop regions that project to-
ward the dimer-of-dimers interface, including residues
near the N terminus of the NA domain (121, 122, 124,
125), the 204 loop (204–205), the 533 loop (532–534),
and K171. These regions are not the most variable re-
gions of the NA domain, but they are also not particu-
larly well conserved in the different HN proteins (Figure
1C), suggesting that the arrangement is not a very
strong or highly conserved interaction. However, the
SV5 HN tetramer is similar to a proposed tetramer ar-
rangement observed for the NDV HN monomer in multi-
ple crystal forms (Zaitsev et al., 2004). The SV5 and
NDV HN tetramers do show significant differences in
the dimer-of-dimers packing, with one dimer shifted
and rotated compared to the other (Figure 7C). This
shift could be due to differences in the HN proteins, due
to the differing crystal lattices or conditions, or could
indicate that tetramerization of the NA domain is gen-
erally weak and adaptable. There are no analogous tet-
ramers formed in the reported structures for HPIV3 HN.
Conclusions
We have determined and analyzed the crystallographic
structure of the SV5 HN ectodomain alone and in com-
plexes with the inhibitor DANA and an authentic recep-
tor, sialyllactose. Sialyllactose was found to bind to the
active site in an intact form at pH 8.0, and the sialic
acid moiety exists in a distorted conformation induced
by interactions with HN. While structural studies of the
HN NA domains from NDV (Crennell et al., 2000; Zaitsev
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812Figure 7. SV5 HN Tetramers
Active sites are marked by space-filling rep-
resentations of the ligand sialyllactose. The
four subunits are shown in different colors.
(A) Top view of the SV5 HN tetramer ar-
rangement.
(B) Side view of the SV5 HN tetramer ar-
rangement, with a 60° packing angle be-
tween dimers.
(C) Side view of the superimposed SV5 HN
and NDV HN tetramers, showing a shift in
dimer packing. SV5 HN is colored blue, and
NDV HN is colored green.
(D) A model for HN tetramer rearrangement
upon cell-surface receptor binding. The HN
tetramer is primarily stabilized by the N-ter-
minal stalk region and can interact with F. Si-
alic acid receptors are displayed at the cell
surface, where binding of the individual HN
NA domains could perturb the NA tetramer
arrangement, consistent with the weak in-
teractions between NA domains. Changes in
the HN NA domain tetramer could affect F
interactions and stimulate membrane fusion.et al., 2004) and HPIV3 (Lawrence et al., 2004) have f
gbeen reported, these have not included complexes with
a model sialic acid receptor such as sialyllactose. In b
Haddition, the SV5 HN ectodomain protein exists as a
tetramer in solution, in contrast to the previous HN H
lstructures. The presence of the HN stalk region is criti-
cal for the formation of stable HN tetramers. However, o
bin the SV5 HN crystal structures, the N-terminal stalk
region is not visible in electron density maps, suggest- f
ring that the connection between the stalk and NA do-
mains is flexible. b
Based on the existing structures and biochemical
evidence, it remains unclear whether the hemagglutinin c
sand NA activities of HN involve one or two separate
sialic acid binding sites (Portner et al., 1987; Thompson t
fand Portner, 1987; Zaitsev et al., 2004). The disparate
theories of one site with dual functions, or of two dis- t
Htinct sites that are intimately related, are both consis-
tent with the observation that sialic acid-derived NA in- a
mhibitors also interfere with receptor binding (Iorio et al.,
2001; Murrell et al., 2003; Scheid and Choppin, 1974). m
tA single site can provide both hemagglutinin and NA
activities by binding sialic acid tightly and hydrolyzing o
fthe molecule slowly (Scheid and Choppin, 1974). The
SV5 HN structure with intact sialyllactose bound in the i
wactive site, but not at a second putative receptor bind-
ing site observed for NDV HN, provides further support c
tfor a single site model for HN action.
Structural studies of NDV HN (Crennell et al., 2000) t
isuggested that the NA domain could form two distinct
dimeric assemblies that were hypothesized to be ligand
tdependent. One of the dimers, observed after cocrys-
tallization with ligand, formed an extensive buried inter- t
Sface, while the second dimer, crystallized in the ab-
sence of ligand and at low pH, formed a much smaller f
minterface. Conformational changes were observed in
the active site of the HN protein upon ligand binding m
rthat were correlated with changes in the dimer inter-ace, suggesting a possible mechanism for coupling li-
and recognition to changes in the oligomeric assem-
ly of the HN protein. A model for the mechanism of
N action in membrane fusion was proposed in which
N engagement of sialic acid through the active site
eads to dimerization (and potentially tetramerization)
f the NA domain, thus generating a second sialic acid
inding site that would then function in adhesion. The
ormation of the HN dimer and tetramer would lead to
elease of F and its subsequent activation in mem-
rane fusion.
Our structural studies of SV5 HN do not support the
onclusion that there is a second sialic acid binding
ite common to HNs of different paramyxoviruses or
hat there are ligand-dependent oligomerization or con-
ormational changes in the protein structure. Moreover,
he dimer of HN that is observed in the SV5 (and HPIV3)
N structures occurs in the absence of ligand binding,
nd there is no crystallographic evidence that mono-
eric ligand binding influences the oligomeric arrange-
ent for these HN proteins. The stalk region appears
o be critical for stabilizing the tetramer in the absence
f ligand, although ligand binding could in principle af-
ect the HN oligomer. It remains unclear how changes
n the HN NA domain may influence the HN stalk region,
hich has been implicated by functional studies to
ontain the primary sites for specificity of the HN/F in-
eraction. Mutagenesis studies have also demonstrated
hat the stalk region of NDV HN can affect the NA activ-
ty and fusion promotion activity (Wang and Iorio, 1999).
While the mechanism by which HN binding to recep-
ors can trigger F activation remains to be understood,
he structural and functional studies of NDV, HPIV3, and
V5 HN proteins do demonstrate that HNs from dif-
erent viruses form similar dimer and potentially tetra-
eric arrangements. The stabilization of the HN tetra-
er and NA domain interactions by the N-terminal stalk
egion suggests that rearrangement or partial dissoci-
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813ation of the HN NA domains may not require a signifi-
cant amount of energy. Based on the structural analy-
sis, it would appear that NA domain dimer interactions
are of higher affinity, since the interface is larger and
the arrangement is well conserved across three para-
myxovirus HN proteins. The dimer of dimers appears to
be a weaker interaction that is less well conserved and
perhaps much easier to perturb with a lower energy
penalty. The rearrangement of the HN dimer or tetra-
mer, in particular through changes in the HN NA domain
interactions, could be a critical feature of the F protein
activation process.
We propose an alternative model for HN involvement
in membrane fusion that is consistent with the available
data and that involves ligand-dependent changes in the
HN oligomer that are driven by surface:surface interac-
tions (Figure 7D). In this model, the HN dimer/tetramer
forms in the absence of ligands and can interact with
the F protein, potentially through lateral interactions on
two sides of the tetramer. Engagement of cell surface
receptors could trigger the partial disassembly of the
HN tetramer, assuming that the energy of binding of the
individual HN active sites to distinct sialic acid recep-
tors is sufficient to perturb the weak NA domain in-
teractions. Opening of the tetrameric head, driven by
the energy of receptor engagement, could lead to
changes in both the HN stalk region and the interaction
with F, thus activating F for membrane fusion.
Experimental Procedures
Construction of Expression Vectors
The HNecto and HNNA fragments were amplified separately by PCR
from SV5 HN cDNA (Hiebert et al., 1985) and were cloned into the
baculovirus transfer vector pBACgus-3 (Invitrogen) at the SmaI/
XhoI sites. Clones were identified and verified by DNA sequencing.
The cloning strategy leaves three extra residues (SPG) after entero-
kinase cleavage at the N terminus of HNecto (residue 37) and HNNA
(residue 115). Both recombinant proteins terminate at residue 565.
Insect Cell Expression
Baculovirus transfer vectors containing HNecto or HNNA inserts
were cotransfected with Baculogold DNA (Pharmingen) into Sf9 in-
sect cells at 2 × 106 cells/ml grown in a T-25 flask with SF 900 II
serum-free medium (GIBCO-BRL) by using standard calcium phos-
phate conditions (Pharmingen). Virus stocks were produced in SF+
cells (Protein Sciences) by using standard procedures. Using SF+
cells, optimized harvest times were determined to be 60 hr and 72
hr postinfection for the production of HNecto and HNNA, respec-
tively.
Protein Preparation
Baculovirus-infected cells expressing HN were pelleted by centrifu-
gation (13,000 × g, 30 min at 4°C), and one-tenth volume of 10×
phosphate buffer (Qiagen) was added to the supernatant. The
crude supernatant containing soluble, secreted HN protein was
loaded onto a pre-equilibrated Ni-NTA column (Qiagen). The col-
umn was washed with 3× bed volumes of 10 mM imidazole in 1×
phosphate buffer and further washed with 1× bed volume each of
10 mM and 20 mM imidazole in 1× phosphate buffer (Qiagen). The
affinity-purified proteins were concentrated by ultrafiltration (Milli-
pore) and dialyzed against enterokinase reaction buffer without
calcium, and the N-terminal fusion tags were cleaved by using en-
terokinase. Enterokinase was removed by using a capture column
(Novagen), and the cleaved fusion tags were separated from the
HN proteins by repurification over Ni-NTA resin. Cleaved HNecto
was further purified by using size-exclusion chromatography
(Superdex-200) in 25 mM Tris (pH 8.0), 200 mM NaCl. Protein con-
centrations were determined by absorbance at 280 nm by usingcalculated extinction coefficients of 1.47 and 1.57 cm−1(mg/ml)−1
for HNecto and HNNA, respectively. The HNecto protein was concen-
trated to 10 mg/ml in 20 mM Tris (pH 7.4), 50 mM NaCl for crystalli-
zation.
Protein Characterization
Recombinant HN was separated by SDS-PAGE and was detected
by staining with Coomassie brilliant blue or by immunoblotting. The
HN protein was detected on blots by using His-tag-specific mono-
clonal antibody (Qiagen), followed by alkaline phosphatase-conju-
gated goat anti-mouse IgG. Detection was performed by using En-
hanced Chemiluminescence (ECL) and was visualized by using a
STORM phosphoimager (Amersham). Protein molecular weights
were assessed by SDS-PAGE (reducing and nonreducing condi-
tions) and by size exclusion chromatography. NA activities were
measured by detection of released sialic acid from sialyllactose by
using the thiobarbituric acid assay (Warren, 1959).
Crystallization and Data Collection
HNecto protein was crystallized at 18°C by the hanging drop vapor
diffusion method. Drops containing 0.8 µl 10 mg/ml protein in 20
mM Tris (pH 7.4), 50 mM NaCl were mixed with the same volume
of precipitant (10 mM Tris pH 8.0, 10% polyethylene glycol 2000
MME) and equilibrated over a well containing 600 µl precipitant
solution. Crystals appeared in 5 days as needles and grew into
long, thin hexagonal rods with maximum dimensions of 0.4 × 0.02 ×
0.02 mm in 3 weeks. Crystals were harvested into a stabilizing
buffer (10 mM Tris pH 8.0, 14% polyethelene glycol 2000 MME, 250
mM NaCl).
Harvested crystals could be transferred to pH 7 and soaked with
ligands without any deterioration in diffraction. Crystals were flash-
cooled in cryoprotectant solutions containing 25% polyethelene
glycol 2000 MME, 250 mM NaCl, and 10% glycerol at either pH 7
or pH 8. When forming complexes, ligands were added into the
stabilizing and cryoprotectant solutions at the following concentra-
tions: 8 mM or 30 mM sialic acid, 8 mM DANA, and 10 mM or 15
mM sialyllactose (either a mixture of 2-3#- and 2-6#- or purified
2-3#-siallylactose). Crystals were soaked in sialic acid or DANA
overnight or in sialyllactose at the pH values and time points indi-
cated in Table 3.
Diffraction data were collected at the COM-CAT beamline at the
Advanced Photon Source by using a Mar CCD detector. Data were
processed and scaled with the HKL suite of programs (Otwinowski
and Minor, 1997). The crystals belong to space group P6122 with
unit cell dimensions (a = b = 137.5 Å, c = 184.8 Å) that remain
similar for all data sets.
Structure Determination and Refinement
Molecular replacement was performed by using the SV5 HN unli-
ganded data set and NDV HN (PDB code 1E8T) as a search model,
providing a clear solution for a single monomer in the asymmetric
unit. The structure was rebuilt and refined to crystallographic Rwork
and Rfree values near 30% at 2.6 Å by using the programs O (Jones
et al., 1991) and CNS (Brunger et al., 1998). Further higher-resolu-
tion refinement (2.3 Å) was performed by using a DANA-soaked
data set, using the same test reflections to 2.6 Å along with addi-
tional reflections between 2.6 and 2.3 Å, providing the initial refined
structure for the remaining data sets. In order to test for any poten-
tial ligand or active site electron density bias from the DANA-
refined model, composite omit electron density maps were also
calculated in parallel with the partially refined native model for
comparison. Geometric parameters of the refined model were ana-
lyzed with PROCHECK (Laskowski et al., 1993) and WHATCHECK
(Hooft et al., 1996).
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